Research programme: pain and neurological disorder therapeutics - CSIRO/NeuroDiscovery
Latest Information Update: 16 Sep 2011
At a glance
- Originator NeuroDiscovery
- Developer CSIRO; NeuroDiscovery
- Class
- Mechanism of Action Gap junction modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neuralgia; Neurological disorders; Pain